Voyager Therapeutics, Inc. (VYGR)
2.18
-0.09
(-3.96%)
USD |
NASDAQ |
Oct 13, 15:46
Voyager Therapeutics Gross Profit Margin (Quarterly) : 71.31% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.31% |
| March 31, 2026 | 64.06% |
| December 31, 2025 | 93.16% |
| September 30, 2025 | 93.03% |
| June 30, 2025 | 79.52% |
| March 31, 2025 | 84.33% |
| December 31, 2024 | 83.90% |
| September 30, 2024 | 95.40% |
| June 30, 2024 | 95.29% |
| March 31, 2024 | 93.87% |
| December 31, 2023 | 98.52% |
| September 30, 2023 | 79.52% |
| June 30, 2023 | 77.62% |
| March 31, 2023 | 99.29% |
| December 31, 2022 | |
| September 30, 2022 | 96.74% |
| June 30, 2022 | -69.10% |
| March 31, 2022 | -327.4% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.52% |
| Return on Assets | -42.09% |
| Return on Invested Capital | -46.03% |
| Profit Margin (Quarterly) | -773.2% |
| Operating Margin (Quarterly) | -833.9% |
| Return on Net Operating Assets | -246.9% |